ZLDPF — Zealand Pharma A/S/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2068427 ·
Denmark
Last close
$50.26
Market Cap
$3.54B
52W High
$57.67
52W Low
$35.93
ADV30
522
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 34,000,000 | 34,000,000 | -539,000,000 | -394,000,000 | 15,301,000,000 | 3,849,000,000 | 832,000,000 |
| Dec 2025 | 68,915,000 | 68,915,000 | -356,544,000 | -379,115,000 | 15,948,798,000 | 4,576,541,000 | 1,118,185,000 |
| Sep 2025 | 49,569,000 | 49,569,000 | -461,320,000 | -404,233,000 | 16,797,246,000 | 5,972,711,000 | 1,634,645,000 |
| Jun 2025 | 9,088,284,000 | 9,087,874,000 | 8,338,423,000 | 7,573,697,000 | 17,180,064,000 | 7,244,047,000 | 1,571,270,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$6,531,933,000
Investing CF
$-2,248,506,000
Financing CF
$-378,182,000
CapEx
$-69,073,000
Dividends Paid
—
Buybacks
$-345,566,000
EPS Diluted TTM
$91.34
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$6,287,000
Inventory
$0
Receivables
—
ST Investments
$10,532,267,000
EBIT TTM
$7,030,122,000
Pretax Income TTM
$7,001,063,000
Interest Exp TTM
$29,059,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,240,859,648
EBITDA
$6,799,047,168
Free Cash Flow
$4,224,191,744
Enterprise Value
$-10,502,624,256
Total Cash
$14,467,999,744
Total Debt
$414,000,000
Shares Out
70,459,093
Trailing EPS
$13.90
Book Value
$32.52
ROE
56.2%
ROA
34.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 9,214,860,000 | 7,113,523,000 | 6,455,008,000 | 15,948,798,000 | 1,118,185,000 | — | 6,531,933,000 |
| Dec 2024 | 62,691,000 | -1,269,071,000 | -1,078,828,000 | 9,505,600,000 | 888,858,000 | — | -930,816,000 |
| Dec 2023 | 342,788,000 | -577,217,000 | -703,739,000 | 1,979,993,000 | 387,154,000 | — | -425,668,000 |
| Dec 2022 | 103,986,000 | -816,599,000 | -1,202,135,000 | 1,539,806,000 | 723,895,000 | — | -942,311,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.16
News headlines (Yahoo Finance, 1h cache)
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
2026-05-26 15:30 · Yahoo
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
2026-05-26 14:00 · Yahoo
Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
2026-05-14 15:00 · Yahoo
Is Zealand Pharma AS (ZLDPF) Stock Undervalued Right Now?
2026-05-12 13:40 · Yahoo
Zealand Pharma Obesity Trials Shape Future Revenue Potential And Partner Dependence
2026-05-12 02:07 · Yahoo
Zealand Pharma A/S (ZLDPF) Reports Q1 Loss, Lags Revenue Estimates
2026-05-07 11:10 · Yahoo
Zealand Pharma - Execution framework for share buy-back program
2026-05-07 05:05 · Yahoo
Zealand Pharma Announces Financial Results for the First Three Months of 2026
2026-05-07 05:00 · Yahoo
Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
2026-05-07 04:55 · Yahoo
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Top Estimates
2026-05-05 22:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.